{"id":54633,"date":"2026-04-24T00:20:10","date_gmt":"2026-04-24T00:20:10","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/54633\/"},"modified":"2026-04-24T00:20:10","modified_gmt":"2026-04-24T00:20:10","slug":"bmgl-investors-have-opportunity-to-join-basel-medical-group","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/54633\/","title":{"rendered":"BMGL Investors Have Opportunity to Join Basel Medical Group"},"content":{"rendered":"<p>LOS ANGELES, April  23, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MQHjy72J-YcTYbZI4df56JZB-tTCLqLXZI3qrTGlndT99qD1wXZ3gGhU_4GXi49ma0b9ZqxUqmcX_xxf54M_1lG52bUNQwPD-b9YYGP9F6M=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"The Schall Law Firm\">The Schall Law Firm<\/a>, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Basel Medical Group Ltd (\u201cBasel\u201d or \u201cthe Company\u201d) (NASDAQ: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=p4S8H8pda8qjJ15iySyzHX_2Gkt9imRUlWIhHW8qnewNcQWjl_E0NcXnkUONiwx-jUJlUbrRGE-ZGiHwDVOK-YksbvxZO_aiEc0-i5oOT58=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"BMGL\">BMGL<\/a>) for violations of the securities laws.<\/p>\n<p>The investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors.<\/p>\n<p>If you are a shareholder who suffered a loss, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RwXNbGUuGnN_pff9G8AEzvctFVn7sXXkn8m20IeHrXvMIPR9fRyI8yH858HnDJcydR0ZoY7pfoT8tETazD59SBWS2riKl6DK4efcka7hvTrjJq-XEqyERhSaChFdpnrCof-c14UesDYklV6sgZr52_G2J__46Yx55-9ivL23wrM=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"click here to participate\">click here to participate<\/a>.<\/p>\n<p>We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm&#8217;s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5lAxUnUrGaCSfKg5EZqIZUDhmQfx4GMzUgqAxiUtpeGOVXx8EJWqfFuymh8_QxDvJ683NIdmGGz_itLr6eIrj0k0OlwA4BY9sDXKiA-5ziQ=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"www.schallfirm.com\">www.schallfirm.com<\/a>, or by email at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OEabv-mQ3kPj7MucEDuvQdFrTKp_vRHzwXtdGNI30Fnh_bcvMZxUSPeFFU4RoIX_k_rNMwrc8gQWD6vbpEzybzjy8E0qjsYI25KEDLHxbpg=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"bschall@schallfirm.com\">bschall@schallfirm.com<\/a>.<\/p>\n<p>The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.<\/p>\n<p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p>\n<p>CONTACT:<\/p>\n<p>The Schall Law Firm\u00a0<br \/>Brian Schall, Esq.\u00a0<br \/>310-301-3335<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-Sl1XoFJdXOF7Tj7nONDEJiFJBJF0jcUrTQU_BPxWiP7qhbvOqUasjjqBag3_38-8glgLCfpHfXzHQzgtj460U-s4LHP3OvVZwTGtPLAUtQ=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"info@schallfirm.com\">info@schallfirm.com<\/a><\/p>\n<p><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5lAxUnUrGaCSfKg5EZqIZfIpVW2cDcD6nfUuA_rHzIFk1NTw0wZc2W2jCwAbrYeGJaJdFhRvvcAqRGvPvh4HTARdReZ8iIuOKitdBbxesPU=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"www.schallfirm.com\">www.schallfirm.com<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/04\/Schall-Law.png\" referrerpolicy=\"no-referrer-when-downgrade\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"LOS ANGELES, April 23, 2026 (GLOBE NEWSWIRE) &#8212; The Schall Law Firm, a national shareholder rights litigation firm,&hellip;\n","protected":false},"author":2,"featured_media":54634,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[8],"tags":[77,30644,22344,30645,30643],"class_list":["post-54633","post","type-post","status-publish","format-standard","has-post-thumbnail","category-basel","tag-basel","tag-basel-medical","tag-bmgl","tag-class-action","tag-schall-law"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116456824701138235","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/54633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=54633"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/54633\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/54634"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=54633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=54633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=54633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}